DK507685D0 - Tricycliske pyridinderivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige udgangsmaterialer - Google Patents

Tricycliske pyridinderivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige udgangsmaterialer

Info

Publication number
DK507685D0
DK507685D0 DK507685A DK507685A DK507685D0 DK 507685 D0 DK507685 D0 DK 507685D0 DK 507685 A DK507685 A DK 507685A DK 507685 A DK507685 A DK 507685A DK 507685 D0 DK507685 D0 DK 507685D0
Authority
DK
Denmark
Prior art keywords
preparation
materials used
pyridine derivatives
present materials
tricyclic pyridine
Prior art date
Application number
DK507685A
Other languages
English (en)
Other versions
DK507685A (da
Inventor
Ulf Fischer
Fernand Schneider
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK507685D0 publication Critical patent/DK507685D0/da
Publication of DK507685A publication Critical patent/DK507685A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK507685A 1984-11-06 1985-11-04 Tricycliske pyridinderivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige udgangsmaterialer DK507685A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530484 1984-11-06
CH383685 1985-09-05

Publications (2)

Publication Number Publication Date
DK507685D0 true DK507685D0 (da) 1985-11-04
DK507685A DK507685A (da) 1986-05-07

Family

ID=25693960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK507685A DK507685A (da) 1984-11-06 1985-11-04 Tricycliske pyridinderivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige udgangsmaterialer

Country Status (23)

Country Link
US (2) US4735940A (da)
EP (2) EP0183994B1 (da)
JP (1) JPH0692405B2 (da)
CN (1) CN1016871B (da)
AR (1) AR242579A1 (da)
AT (1) ATE51232T1 (da)
AU (1) AU584132B2 (da)
CA (1) CA1277659C (da)
DE (2) DE3576691D1 (da)
DK (1) DK507685A (da)
DO (1) DOP1985004378A (da)
ES (8) ES8705436A1 (da)
FI (1) FI89049C (da)
GB (1) GB2169288B (da)
HU (1) HU205353B (da)
IE (1) IE58850B1 (da)
IL (1) IL76894A (da)
IS (1) IS1469B6 (da)
MC (1) MC1707A1 (da)
MY (1) MY103172A (da)
NO (1) NO171914C (da)
PT (1) PT81431B (da)
ZW (1) ZW17385A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
CA1317945C (en) * 1985-12-13 1993-05-18 Ulf Fischer Tricyclic pyridazopyridone derivatives
EP0294599A3 (de) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Tricyclische Pyridonderivate
EP0465254B1 (en) * 1990-07-06 1996-11-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused thiophene compounds and uses thereof
CA2058640A1 (en) * 1991-01-25 1992-07-26 Richard R. Scherschlicht Tricyclic pyridone derivative
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
GB9708945D0 (en) * 1997-05-01 1997-06-25 Merck Sharp & Dohme Therapeutic agents
GB0119803D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
GB0119828D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
AU2007208452B2 (en) 2006-01-13 2012-07-05 The Trustees Of The University Of Pennsylvania Vaccines and immunotherapeutics using codon optimized IL-15 and methods for using the same
RS59991B1 (sr) 2013-08-08 2020-04-30 Scripps Research Inst Metoda enzimskog in vitro obeležavanja specifičnog za položaj nukleinskih kiselina uvođenjem neprirodnih nukleotida

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191763A (en) * 1978-10-13 1984-05-31 Hoffmann La Roche 7-beta-phenyl-quinolidines, intermediates and pharmaceutical compositions
EP0067565A1 (en) * 1981-06-16 1982-12-22 Beecham Group Plc Pharmaceutically active compounds
GB8408292D0 (en) * 1984-03-30 1984-05-10 Fujisawa Pharmaceutical Co Quinolizinone compound
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
GB8509435D0 (en) * 1985-04-12 1985-05-15 Beecham Group Plc Intermediates & process
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines

Also Published As

Publication number Publication date
IE58850B1 (en) 1993-11-17
NO854404L (no) 1986-05-07
ZW17385A1 (en) 1986-02-19
IS3054A7 (is) 1986-05-07
CN85108120A (zh) 1986-11-05
IS1469B6 (is) 1991-09-24
EP0318682A2 (de) 1989-06-07
MY103172A (en) 1993-05-29
PT81431A (en) 1985-12-01
CA1277659C (en) 1990-12-11
ES8800937A1 (es) 1987-12-01
ES548532A0 (es) 1987-05-01
ES8800932A1 (es) 1987-12-01
FI89049B (fi) 1993-04-30
DK507685A (da) 1986-05-07
US5036066A (en) 1991-07-30
ES8800933A1 (es) 1987-12-01
ES554428A0 (es) 1987-12-01
ATE51232T1 (de) 1990-04-15
JPS61115082A (ja) 1986-06-02
DE3587235D1 (en) 1993-05-06
US4735940A (en) 1988-04-05
GB2169288A (en) 1986-07-09
ES554431A0 (es) 1987-12-01
IL76894A (en) 1989-06-30
GB2169288B (en) 1989-06-01
MC1707A1 (fr) 1986-09-22
ES8800936A1 (es) 1987-12-01
EP0318682A3 (en) 1989-08-16
AR242579A1 (es) 1993-04-30
AU584132B2 (en) 1989-05-18
ES554430A0 (es) 1987-12-01
IE852751L (en) 1986-05-06
ES8800934A1 (es) 1987-12-01
ES554426A0 (es) 1987-12-01
ES8705436A1 (es) 1987-05-01
IL76894A0 (en) 1986-02-28
AU4924185A (en) 1986-05-15
DOP1985004378A (es) 1991-04-05
DE3576691D1 (de) 1990-04-26
ES554432A0 (es) 1987-12-01
ES554427A0 (es) 1987-12-01
JPH0692405B2 (ja) 1994-11-16
EP0318682B1 (de) 1993-03-31
GB8527196D0 (en) 1985-12-11
HU205353B (en) 1992-04-28
NO171914C (no) 1993-05-19
ES8800939A1 (es) 1987-12-01
EP0183994B1 (de) 1990-03-21
CN1016871B (zh) 1992-06-03
EP0183994A1 (de) 1986-06-11
ES8800935A1 (es) 1987-12-01
PT81431B (pt) 1988-03-03
HUT38638A (en) 1986-06-30
NO171914B (no) 1993-02-08
FI89049C (fi) 1993-08-10
ES554429A0 (es) 1987-12-01
FI854211A0 (fi) 1985-10-28

Similar Documents

Publication Publication Date Title
DK559985D0 (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK504485D0 (da) Substituerede azolylmethyl-cyclopropyl-carbinol-derivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DK520285D0 (da) 5-amino-4-hydroxyvalerylderivater samt deres fremstilling og anvendelse
DK507685A (da) Tricycliske pyridinderivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige udgangsmaterialer
DK578185D0 (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK420785A (da) 13-halogen- eller 13-hydroxymilbemyciner samt deres fremstilling og anvendelse
DK28685D0 (da) Azolyl-aryl-alkanol-derivater, deres fremstilling og anvendelse
DK256885A (da) Milbemycin-derivater samt deres fremstilling og anvendelse til skadedyrsbekaempelse
DK81586D0 (da) Tricycliske 1,2-dihydronaphthalenderivater samt deres fremstilling og anvendelse
DK537785A (da) Flavolignanderivater samt deres fremstilling og anvendelse
DK393285A (da) Substituerede carbonylphenylsulfonylguanidiner samt deres fremstilling og anvendelse
DK236585D0 (da) Acylerede hexosederivater samt deres fremstilling og anvendelse
DK119585D0 (da) 1,2,4-triazacycloalkadienderivater samt deres fremstilling og anvendelse
DK77186A (da) 1,4,6-tri-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DK422685A (da) Benzazolderivater samt deres fremstilling og anvendelse
DK136985D0 (da) Sulfamoylguanidin-derivater, deres fremstilling og anvendelse
DK402585A (da) Pseudooligosaccharider med alfa-glucosidase-inhiberende virkning, deres fremstilling og anvendelse samt farmaceutiske praeparater
DK153285D0 (da) Benzodioxolderivater samt deres fremstilling og anvendelse
DK314085A (da) 4-substituerede-1,2,4,6-thiatriazin-derivater, deres fremstilling oganvendelse, samt ved fremstillingen anvendeligt udgangsstof og fremstilling deraf
DK181485A (da) 3-substituerede thiopyroner samt deres fremstilling og anvendelse
DK136885A (da) Thiatriazin-derivater, deres fremstilling og anvendelse
DK361185D0 (da) 2-aminoalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK447687D0 (da) Urdamycin g og derivater deraf samt deres fremstilling og anvendelse
DK117587A (da) 5-acyloxy-13beta-alkyl-milbemycin-derivater samt deres fremstilling og anvendelse
DK133687A (da) Pyridinderivater samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment